Male circumcision andMycoplasma genitaliuminfection in female partners: a randomised trial in Rakai, Uganda
Year: 2013
Type: article
Abstract: OBJECTIVE: Previous randomised trial data have demonstrated that male circumcision reduces Mycoplasma genitalium prevalence in men. We assessed whether male circumcision also reduces M genitalium infection in female partners of circumcised men. METHODS: HIV-negative men were enrolled and randomised to either male circumcision or control. Female partners of male trial participants from the intervention (n=437) and control (n=394) arms provided interview information and self-collected vaginal swabs that were tested for M genitalium by APTIMA transcription-mediated amplification-based assay. Prevalence risk ratios (PRR) and 95% CI of M genitalium prevalence in intervention versus control group were estimated using Poisson regression. Analysis was by intention-to-treat. An as-treated analysis was conducted to account for study-group crossovers. RESULTS: Male and female partner enrolment sociodemographic characteristics, sexual behaviours, and symptoms of sexually transmitted infections were similar between study arms. Female M genitalium prevalence at year 2 was 3.2% (14/437) in the intervention arm and 3.6% (14/394) in the control arm (PRR=0.90, 95% CI 0.43 to 1.89, p=0.78). In an as-treated analysis, the prevalence of M genitalium was 3.4% in female partners of circumcised men and 3.3% in female partners of uncircumcised men (PRR=1.01, 95% CI 0.48 to 2.12, p=0.97). CONCLUSIONS: Contrary to findings in men, male circumcision did not affect M genitalium infection in female partners.
Source: Sexually Transmitted Infections
Language: English
Topic: Genital Health and Disease
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Foundation for the National Institutes of Health, Doris Duke Charitable Foundation, Bill and Melinda Gates Foundation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, U.S. Public Health Service, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Institute of Biomedical Imaging and Bioengineering
Awards: G1016888045, G1163076886, G2248094476, Oncogenic HPV, Mucosal Immune Response and Risk of HIV Acquisition, G3194468473, Male Circumcision Trial for HIV Prevention, Rakai-Uganda, HIV Prevention Trials Network: Network Laboratory, International Training/Research in Population and Health, Uganda, SPECIAL POSTDOCTORAL RESEARCH PROGRAM IN AIDS, Center for Innovative Diagnostics for Infectious Diseases, LC: HIV PREVENTION TRIALS NETWORK
OpenAlex ID: W2118685780
